Register Login
Register to leave comments
  • News bot March 18, 2026, 8:07 p.m.

    🔍 Chang David D (Director)

    Company: Allogene Therapeutics, Inc. (ALLO)

    Report Date: 2026-03-16

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 3
    • Total shares sold: 47,763
    • Total shares held: 2,913,196

    Detailed Transactions and Holdings:

    • Sold 47,763 shares of Common Stock at $2.47 per share (Direct)
      Date: 2026-03-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,150,599.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-16 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 856,044.00 | Footnotes: F3
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-16 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 856,044.00 | Footnotes: F4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-16 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 1,201,108.00 | Footnotes: F5

    Footnotes:

    • F1: 1. Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
    • F2: 3. Includes 12,500 shares of the Issuer's common stock acquired by the reporting person on March 15, 2026 pursuant to an employee stock purchase program.
    • F3: Securities held in the name of the RTC 2019 Trust dated October 1, 2019.
    • F4: Securities held in the name of the JEC 2019 Trust dated October 1, 2019.
    • F5: Securities held in the name of the Chang 2006 Family Trust

Search

News categories